By Mike Adams

A growing body of research suggests a deliberate effort to suppress natural light exposure, with far-reaching consequences for public health. The medical establishment, pharmaceutical interests, and government agencies have allegedly prioritized artificial lighting, chemical sunscreens, and indoor lifestyles over the benefits of sunlight, creating conditions that exacerbate chronic illness and dependency on synthetic treatments.

Sunlight is essential for vitamin D production, a hormone critical to immune function, cancer prevention, and hormonal balance. Over one billion people globally suffer from vitamin D deficiency, linked to indoor-centric modern life and fear-driven campaigns against sun exposure. This deficiency is tied to rising rates of cancer, diabetes, and autoimmune disorders, all while pharmaceutical companies profit from treating these conditions rather than addressing their root cause: light deprivation.

Emerging studies highlight another alarming angle: melanin’s role in shielding the body from harmful electromagnetic fields (EMFs). Research published in Nature Communications demonstrates that melanin-like structures can block 5G radiation, converting it into heat rather than allowing it to penetrate deeper tissues. This natural defense mechanism is compromised when individuals avoid sunlight, leaving them vulnerable to EMF-related damage.

Modern lighting technologies further compound the issue. Incandescent bulbs, which mimic the sun’s full-spectrum light, have been phased out in favor of LED and fluorescent lights that lack near-infrared (NIR) wavelengths. These infrared frequencies are vital for mitochondrial function, cellular repair, and reducing inflammation. The shift to blue-dominant lighting disrupts circadian rhythms, accelerates aging, and weakens the body’s natural healing processes.

Experts like Scott Chaverri of Mito Red Light argue that red-light therapy could mitigate some of these effects by replicating sunlight’s beneficial wavelengths. However, such solutions remain underutilized as institutions continue to promote artificial alternatives.

The article also raises questions about the suppression of phototherapy, a treatment unpatentable and thus unprofitable for pharmaceutical giants. Advocates suggest that natural sunlight and targeted light therapies could reduce reliance on costly medical interventions, but systemic barriers persist.

As debates over health, technology, and control intensify, the role of light in human well-being remains a contentious and underexplored frontier.